钛媒体:引领未来商业与生活新知 前天 16:09
China’s BrainCo Seeks Pre-IPO Funding at $1.3 Billion Valuation
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

中国脑机接口(BCI)初创公司BrainCo正与潜在投资者商谈,计划在香港或中国内地进行首次公开募股(IPO),募资约1亿美元,公司估值预计将超过13亿美元。BrainCo成立于2015年,专注于仿生假肢和神经接口技术,旨在实现人脑对计算机的控制。该公司是杭州“六小龙”之一,与DeepSeek、阿里巴巴等知名科技公司并列。BrainCo的融资举动反映了中国风险投资市场对下一代科技初创企业的兴趣正在复苏,此前该市场曾因疫情和监管政策而陷入停滞。中国的早期科技领域正迎来新的创业浪潮,BrainCo的成功将进一步激励该行业的发展。

🧠 BrainCo是一家中国脑机接口(BCI)初创公司,其目标是与埃隆·马斯克的Neuralink竞争。该公司正就上市前融资进行谈判,计划筹集约1亿美元,公司估值将超过13亿美元,为在香港或中国内地上市做准备。这显示了中国在脑机接口这一前沿科技领域的积极发展态势。

💡 BrainCo成立于2015年,由哈佛校友韩冰成创立,官方名称为浙江强脑科技有限公司。公司主要业务聚焦于仿生假肢和能够实现人脑控制计算机的神经接口技术。其总部位于杭州,是当地充满活力的科技创新群体“六小龙”之一,该群体还包括AI公司DeepSeek和电商巨头阿里巴巴。

💰 BrainCo的融资动态反映了中国风险投资市场对下一代科技初创企业的投资兴趣正在回暖。在经历了几年的疫情影响和监管调整后,中国的风险投资生态系统正显现复苏迹象,顶级风投机构正积极寻求新的资金,尤其是在人工智能、机器人和先进制造等领域。BrainCo的融资成功也为其他早期科技公司注入了信心。

🚀 BrainCo并非中国脑机接口领域的唯一参与者。上海的StairMed Technology也成功完成了近5000万美元的B轮融资,并启动了中国首个侵入式脑机接口的临床试验。这表明中国在脑机接口技术研发和应用方面正处于快速追赶和竞争之中,市场潜力巨大。


Credit: CFP


AsianFin -- BrainCo, a Chinese brain-computer interface (BCI) startup aiming to rival Elon Musk’s Neuralink, is in talks to raise about $100 million in pre-IPO funding at a valuation exceeding $1.3 billion, as it prepares for a potential listing in Hong Kong or mainland China, according to people familiar with the matter.

Founded in 2015 by Harvard alumnus Han Bicheng, BrainCo—officially known as Zhejiang Qiangnao Technology Co.—has started early-stage preparations for a public offering, the people said, asking not to be identified discussing private information. The company has yet to finalize its listing venue or timeline, they added.

Based in Hangzhou, BrainCo is part of the so-called “Six Little Dragons”—a cohort of China’s most promising tech innovators that includes AI startup DeepSeek and e-commerce giant Alibaba Group Holding Ltd. The company specializes in bionic prosthetics and neural interface technology that enables humans to control computers with their minds.

BrainCo isn’t alone in China’s fledgling BCI race. Earlier this year, Shanghai-based StairMed Technology raised 350 million yuan ($48.7 million) in Series B financing and launched China’s first clinical trial for invasive brain-computer interfaces, local media outlet Yicai reported. BrainCo’s founder previously told the South China Morning Post he was considering an expansion into Hong Kong.

Talks around BrainCo’s financing and IPO remain fluid, and details could shift depending on market dynamics, the people said. Representatives for BrainCo did not respond to requests for comment.

The company’s funding efforts highlight growing investor appetite for next-generation tech startups in China, as the country’s venture capital ecosystem shows signs of revival after years of Covid-era stagnation and regulatory crackdowns. China’s top VC firms are now seeking to raise at least $2 billion in fresh funds, rekindling interest in sectors like AI, robotics, and advanced manufacturing.

Breakout successes like BrainCo, DeepSeek, and robotics firm Manus have galvanized a new wave of entrepreneurial activity, particularly in Hangzhou. The city’s “Six Little Dragons” also include game developer Game Science, known for the blockbuster title Black Myth: Wukong, as well as Deep Robotics, Unitree Robotics, and AI computing startup Manycore.

The resurgence of China’s early-stage tech scene underscores a broader reassessment by global investors, as signs of recovery emerge across the country’s startup ecosystem and macroeconomy.

更多精彩内容,关注钛媒体微信号(ID:taimeiti),或者下载钛媒体App

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

BrainCo 脑机接口 BCI 科技融资 中国科技
相关文章